Office: Foege N530M
Targeted drug delivery
Nanotechnology has recently received broad interest from biomedical researchers and may change the very foundations of disease diagnosis, treatment and prevention. From technology development side, currently we are developing semiconductor quantum dots (Qdots) for optical imaging, magnetic nanoparticles for MRI and magnetic manipulation, metallic nanoparticles for photoacoustic imaging and image-guided therapy, and polymeric and natural protein nanoparticles for drug delivery. From the application side, we are interested in molecular screening, diagnosis, prognosis, and treatment. In general, we are interested in any innovative nanotechnology that has impact on biology and medicine.
BS, Chemistry, Nankai University, China, 1998
2010 Faculty innovator award, College of Engineering, University of Washington
2007 CAREER Award, National Science Foundation
BIOEN 599: Grad Imaging 2: Optical Bio-Imaging
X.H. Gao, Y. Cui, R.M. Levenson, L.W.K. Chung, and S.M. Nie, “In vivo cancer targeting and imaging with semiconductor quantum dots,” Nature Biotechnology 2004, 22, 969-976.
Y.D. Jin and X.H. Gao, Plasmonic fluorescent quantum dots, Nature Nanotechnology. 2009, 4, 571-576
Y.D. Jin , C. Jia , S.W. Huang, M. O’Donnell and X.H. Gao, Multifunctional nanoparticles as coupled contrast agents, Nature Communications, 2010, 10.1038/ncomms1042.
P. Zrazhevskiy, X.H. Gao, Quantum dot imaging platform for single-cell molecular profiling, Nature Communications, doi: 10.1038/ncomms2635, 2013.
P. Zrazhevskiy, L.D. True, and X.H. Gao, Multicolor multicycle molecular profiling (M3P) with quantum dots for single-cell analysis, Nature Protocols, 8, 1852-1869, 2013